In March 2025, the company declared new strategies for just a immediate-to-client featuring of its Wegovy weight loss drug. The company proven a new pharmacy, named NovoCare, which might cost consumers $499 monthly for access to the drug, under fifty percent the expense of the drug as a result of other pharmaceutical distribution networks.[fifty th